Artiva Biotherapeutics Ownership | Who Owns Artiva Biotherapeutics?
Artiva Biotherapeutics Ownership Summary
Artiva Biotherapeutics is owned by 68.87% institutional investors, 21.90% insiders, and 9.23% retail investors. Ra capital management is the largest institutional shareholder, holding 40.31% of ARTV shares. Franklin Biotechnology Discv A(acc)USD is the top mutual fund, with 1.32% of its assets in Artiva Biotherapeutics shares.
ARTV Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Artiva Biotherapeutics | 68.87% | 21.90% | 9.23% |
| Sector | Healthcare Stocks | 35.70% | 12.04% | 52.26% |
| Industry | Biotech Stocks | 35.48% | 11.92% | 52.60% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ra capital management | 9.85M | 40.31% | $63.46M |
| 5am venture management | 2.35M | 9.63% | $15.16M |
| Vr adviser | 1.61M | 6.58% | $10.37M |
| Venbio partners | 531.34K | 2.17% | $3.42M |
| Franklin resources | 520.33K | 2.13% | $3.35M |
| Revelation capital management | 299.31K | 1.22% | $1.93M |
| Vanguard group | 246.01K | 1.00% | $1.06M |
| Blackrock funding, inc. /de | 213.39K | 0.87% | $1.37M |
| Wellington management group llp | 194.11K | 0.79% | $1.25M |
| Propel bio management | 146.37K | 0.60% | $949.82K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| 5am venture management | 2.35M | 4.21% | $15.16M |
| Revelation capital management | 299.31K | 2.86% | $1.93M |
| Venbio partners | 531.34K | 1.22% | $3.42M |
| Ra capital management | 9.85M | 0.67% | $63.46M |
| Propel bio management | 146.37K | 0.60% | $949.82K |
| Vr adviser | 1.61M | 0.39% | $10.37M |
| Velan capital investment management lp | 25.00K | 0.10% | $161.00K |
| Bridgeway capital management | 35.00K | 0.00% | $225.40K |
| Bailard | 20.70K | 0.00% | $133.31K |
| Xtx topco | 20.27K | 0.00% | $130.54K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Propel bio management | 146.37K | 0.60% | 146.37K |
| Vanguard group | 246.01K | - | 86.89K |
| Vanguard fiduciary trust | 32.81K | 0.00% | 32.81K |
| Panagora asset management | 30.70K | 0.00% | 30.70K |
| Velan capital investment management lp | 25.00K | 0.10% | 25.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Capital world investors | - | - | -866.62K |
| Samsara biocapital | - | - | -291.67K |
| Woodline partners lp | - | - | -283.12K |
| Rtw investments, lp | - | - | -148.84K |
| Logos global management lp | - | - | -145.09K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Propel bio management | 146.37K | 0.60% | 146.37K | $949.82K |
| Vanguard fiduciary trust | 32.81K | 0.00% | 32.81K | $211.30K |
| Panagora asset management | 30.70K | 0.00% | 30.70K | $197.72K |
| Velan capital investment management lp | 25.00K | 0.10% | 25.00K | $161.00K |
| Simplify asset management | 23.23K | 0.00% | 23.23K | $149.60K |
Sold Out
| Holder | Change |
|---|---|
| Gamma investing | -15.00 |
| Sterling capital management | -158.00 |
| Eversource wealth advisors | -159.00 |
| Cwm | -185.00 |
| Nelson, van denburg & campbell wealth management group | -224.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 40 | 17.65% | 16,834,466 | -0.72% | 68 | 1.44% | 15 | 50.00% | 12 | -20.00% |
| Dec 31, 2025 | 2 | -94.87% | 282,879 | -98.44% | 1 | 0.02% | 2 | -84.62% | - | -100.00% |
| Sep 30, 2025 | 7 | -85.11% | 274,587 | -98.52% | 1 | 0.02% | 4 | -80.95% | 3 | -80.00% |
| Jun 30, 2025 | 46 | -13.21% | 18,502,865 | -11.55% | 75 | 1.03% | 20 | -23.08% | 15 | 25.00% |
| Mar 31, 2025 | 53 | -7.02% | 20,919,893 | -1.14% | 185 | 0.53% | 26 | -7.14% | 12 | 100.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Franklin Biotechnology Discv A(acc)USD | 327.43K | 1.32% | - |
| Franklin Biotechnology Discovery A | 192.87K | 0.78% | - |
| Vanguard Total Stock Mkt Idx Inv | 148.20K | 0.60% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 66.56K | 0.27% | 7.07K |
| Simplify Propel Opportunities ETF | 101.36K | 0.21% | - |
| Bridgeway Ultra-Small Company Market | 35.00K | 0.14% | - |
| Extended Equity Market Fund B | 32.55K | 0.13% | - |
| Blackrock Extended Mkt Fund CF | 32.55K | 0.13% | - |
| Extended Equity Market Fund E | 32.55K | 0.13% | - |
| BlackRock Extended Equity Market Fund K | 27.71K | 0.11% | -203.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jul 13, 2026 | RA CAPITAL MANAGEMENT, L.P. | Buy | $58.57K | |
| Jul 10, 2026 | RA CAPITAL MANAGEMENT, L.P. | Buy | $135.46K | |
| Jun 26, 2026 | RA CAPITAL MANAGEMENT, L.P. | Buy | $16.85K | |
| Jun 25, 2026 | RA CAPITAL MANAGEMENT, L.P. | Buy | $275.28K | |
| Jun 15, 2026 | RA CAPITAL MANAGEMENT, L.P. | Buy | $138.57K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | 2 | - |
| 2026 Q2 | 12 | 5 |
| 2026 Q1 | - | - |
| 2025 Q4 | - | 3 |
| 2025 Q3 | - | 1 |
ARTV Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools